{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:03:19Z","timestamp":1788966199169,"version":"build-2803163510"},"reference-count":81,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["19927"],"award-info":[{"award-number":["19927"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["23443"],"award-info":[{"award-number":["23443"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2014-1164"],"award-info":[{"award-number":["2014-1164"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancer cachexia consists of dramatic body weight loss with rapid muscle depletion due to imbalanced protein homeostasis. We found that the mRNA levels of apelin decrease in muscles from cachectic hepatoma-bearing rats and three mouse models of cachexia. Furthermore, apelin expression inversely correlates with MuRF1 in muscle biopsies from cancer patients. To shed light on the possible role of apelin in cachexia in vivo, we generated apelin 13 carrying all the last 13 amino acids of apelin in D isomers, ultimately extending plasma stability. Notably, apelin D-peptides alter cAMP-based signaling in vitro as the L-peptides, supporting receptor binding. In vitro apelin 13 protects myotube diameter from dexamethasone-induced atrophy, restrains rates of degradation of long-lived proteins and MuRF1 expression, but fails to protect mice from atrophy. D-apelin 13 given intraperitoneally for 13 days in colon adenocarcinoma C26-bearing mice does not reduce catabolic pathways in muscles, as it does in vitro. Puzzlingly, the levels of circulating apelin seemingly deriving from cachexia-inducing tumors, increase in murine plasma during cachexia. Muscle electroporation of a plasmid expressing its receptor APJ, unlike apelin, preserves myofiber area from C26-induced atrophy, supporting apelin resistance in vivo. Altogether, we believe that during cachexia apelin resistance occurs, contributing to muscle wasting and nullifying any possible peptide-based treatment.<\/jats:p>","DOI":"10.3390\/cancers14071814","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:59:52Z","timestamp":1648954792000},"page":"1814","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-9108","authenticated-orcid":false,"given":"Andrea David","family":"Re Cecconi","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-9209","authenticated-orcid":false,"given":"Mara","family":"Barone","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Forti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lunardi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-8240","authenticated-orcid":false,"given":"Alfredo","family":"Cagnotto","sequence":"additional","affiliation":[{"name":"Molecular Biochemistry and Pharmacology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-9873","authenticated-orcid":false,"given":"Mario","family":"Salmona","sequence":"additional","affiliation":[{"name":"Molecular Biochemistry and Pharmacology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Olivari","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-8155","authenticated-orcid":false,"given":"Lorena","family":"Zentilin","sequence":"additional","affiliation":[{"name":"Molecular Medicine, International Centre for Genetic Engineering and Biotechnology, Via Padriciano 99, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-0815","authenticated-orcid":false,"given":"Andrea","family":"Resovi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Stezzano 87, 24126 Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-7383","authenticated-orcid":false,"given":"Perla","family":"Persichitti","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Stezzano 87, 24126 Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-9144","authenticated-orcid":false,"given":"Dorina","family":"Belotti","sequence":"additional","affiliation":[{"name":"Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Stezzano 87, 24126 Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Palo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takakura","sequence":"additional","affiliation":[{"name":"Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita-shi, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-7816","authenticated-orcid":false,"given":"Hiroyasu","family":"Kidoya","sequence":"additional","affiliation":[{"name":"Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-9352","authenticated-orcid":false,"given":"Rosanna","family":"Piccirillo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/dvdy.24036","article-title":"Mechanisms of muscle growth and atrophy in mammals and drosophila","volume":"243","author":"Piccirillo","year":"2014","journal-title":"Dev. Dyn."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"Pretto","year":"2015","journal-title":"Oncotarget"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.devcel.2015.03.001","article-title":"Malignant drosophila tumors interrupt insulin signaling to induce cachexia-like wasting","volume":"33","author":"Bilder","year":"2015","journal-title":"Dev. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.devcel.2015.02.012","article-title":"Systemic organ wasting induced by localized expression of the secreted Insulin\/IGF antagonist ImpL2","volume":"33","author":"Kwon","year":"2015","journal-title":"Dev. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/onc.2016.153","article-title":"Activation of the SDF1\/CXCR4 pathway retards muscle atrophy during cancer cachexia","volume":"48","author":"Martinelli","year":"2016","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13679-015-0174-7","article-title":"Novel mediators of adipose tissue and muscle crosstalk","volume":"4","author":"Indrakusuma","year":"2015","journal-title":"Curr. Obes. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(02)00411-1","article-title":"Apelin-immunoreactivity in the rat hypothalamus and pituitary","volume":"327","author":"Brailoiu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1152\/ajpendo.00385.2009","article-title":"Apelin is necessary for the maintenance of insulin sensitivity","volume":"298","author":"Yue","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. tissue distribution of MRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1389450115666141128120053","article-title":"Targeting drugs to APJ receptor: The prospect of treatment of hypertension and other cardiovascular diseases","volume":"16","author":"Cao","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphys.2018.00557","article-title":"The role of apelin in cardiovascular diseases, obesity and cancer","volume":"9","author":"Wysocka","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cellsig.2004.09.018","article-title":"Apelin signalling: A promising pathway from cloning to pharmacology","volume":"17","author":"Masri","year":"2005","journal-title":"Cell Signal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"127499","DOI":"10.1016\/j.bmcl.2020.127499","article-title":"Half-Life extension of Peptidic APJ agonists by N-Terminal lipid conjugation","volume":"30","author":"Reed","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"630548","DOI":"10.3389\/fphar.2021.630548","article-title":"The effects of apelin and elabela ligands on apelin receptor distinct signaling profiles","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl Apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Resovi, A., Borsotti, P., Ceruti, T., Passoni, A., Zucchetti, M., Berndt, A., Riser, B.L., Taraboletti, G., and Belotti, D. (2020). CCN-Based therapeutic peptides modify pancreatic ductal adenocarcinoma microenvironment and decrease tumor growth in combination with chemotherapy. Cells, 9.","DOI":"10.3390\/cells9040952"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kawahara, H., Naito, H., Takara, K., Wakabayashi, T., Kidoya, H., and Takakura, N. (2013). Tumor endothelial cell-specific drug delivery system using apelin-conjugated liposomes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065499"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2009-07-232306","article-title":"Apelin Induces enlarged and nonleaky blood vessels for functional recovery from ischemia","volume":"115","author":"Kidoya","year":"2010","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ymthe.2004.08.007","article-title":"Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo","volume":"10","author":"Arsic","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gt.2009.157","article-title":"High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency","volume":"17","author":"Ayuso","year":"2010","journal-title":"Gene Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Re Cecconi, A.D., Forti, M., Chiappa, M., Zhu, Z., Zingman, L.V., Cervo, L., Beltrame, L., Marchini, S., and Piccirillo, R. (2019). Musclin, A Myokine induced by aerobic exercise, retards muscle atrophy during cancer cachexia in mice. Cancers, 11.","DOI":"10.3390\/cancers11101541"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e8741","DOI":"10.15252\/emmm.201708741","article-title":"Soluble stroma-related biomarkers of pancreatic cancer","volume":"10","author":"Resovi","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization of a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J. Cachex-Sarcopenia Muscle"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1096\/fj.15-270579","article-title":"Inactivation of the ubiquitin-specific protease 19 deubiquitinating enzyme protects against muscle wasting","volume":"29","author":"Bedard","year":"2015","journal-title":"FASEB J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fphys.2019.01074","article-title":"Fibro-Adipogenic progenitors cross-talk in skeletal muscle: The social network","volume":"10","author":"Biferali","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M407517200","article-title":"Insulin-like growth Factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-Kinase\/Akt\/Mammalian target of rapamycin (PI3K\/Akt\/MTOR) pathway","volume":"280","author":"Latres","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_40","first-page":"5313","article-title":"The Apelin-APJ system induces tumor Arteriogenesis in hepatocellular carcinoma","volume":"34","author":"Muto","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/en.2006-1270","article-title":"Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice","volume":"148","author":"Higuchi","year":"2007","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Evans, B.J., King, A.T., Katsifis, A., Matesic, L., and Jamie, J.F. (2020). Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals. Molecules, 25.","DOI":"10.3390\/molecules25102314"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1073\/pnas.79.24.7934","article-title":"CAMP-Mediated decrease in K+ conductance evoked by serotonin and dopamine in the same neuron: A biochemical and physiological single-cell study","volume":"79","author":"Deterre","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18317","DOI":"10.1074\/jbc.M600606200","article-title":"The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments","volume":"281","author":"Masri","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4062\/biomolther.2016.186","article-title":"Multifactorial regulation of G protein-coupled receptor endocytosis","volume":"25","author":"Zhang","year":"2017","journal-title":"Biomol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/molpharm.120.000192","article-title":"Arrestin-Dependent and -independent internalization of G protein-coupled receptors: Methods, mechanisms, and implications on cell signaling","volume":"99","author":"Moo","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"ref_47","first-page":"9361","article-title":"Cachexia and pancreatic cancer: Are there treatment options?","volume":"20","author":"Mueller","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20190450","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"218","author":"Rupert","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-021-22361-3","article-title":"Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia","volume":"12","author":"Olson","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mannelli, M., Gamberi, T., Magherini, F., and Fiaschi, T. (2020). The adipokines in cancer cachexia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144860"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"ra80","DOI":"10.1126\/scisignal.2002038","article-title":"G\u03b1i2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration","volume":"4","author":"Minetti","year":"2011","journal-title":"Sci. Signal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","article-title":"CAMP-Induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins","volume":"112","author":"Lokireddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2016.11.025","article-title":"Inhibition of the apelin\/apelin receptor axis decreases cholangiocarcinoma growth","volume":"386","author":"Hall","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e9266","DOI":"10.15252\/emmm.201809266","article-title":"Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy","volume":"11","author":"Uribesalgo","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"619649","DOI":"10.1155\/2014\/619649","article-title":"Serum Levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients","volume":"2014","author":"Diakowska","year":"2014","journal-title":"Dis. Markers"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/mcp.M112.024919","article-title":"Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse","volume":"12","author":"Geiger","year":"2013","journal-title":"Mol. Cell. Proteom."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"aad0189","DOI":"10.1126\/science.aad0189","article-title":"Systems proteomics of liver mitochondria function","volume":"352","author":"Williams","year":"2016","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0378-1119(96)00512-4","article-title":"Expression profiles of active genes in human and mouse livers","volume":"174","author":"Kawamoto","year":"1996","journal-title":"Gene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2016.07.040","article-title":"Agonist-Induced Internalization and Desensitization of the Apelin Receptor","volume":"437","author":"Pope","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ijo.2013.158","article-title":"Effect of endurance training on skeletal muscle myokine expression in obese men: Identification of apelin as a novel myokine","volume":"38","author":"Montastier","year":"2014","journal-title":"Int. J. Obes."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Fujie, S., Sato, K., Miyamoto-Mikami, E., Hasegawa, N., Fujita, S., Sanada, K., Hamaoka, T., and Iemitsu, M. (2014). Reduction of arterial stiffness by exercise training is associated with increasing plasma apelin level in middle-aged and older adults. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093545"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1038\/ncomms11268","article-title":"MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation","volume":"7","author":"Papangeli","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","first-page":"2290","article-title":"Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice","volume":"50","author":"Tanaka","year":"1990","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1073\/pnas.1714703115","article-title":"Fenofibrate prevents skeletal muscle loss in mice with lung cancer","volume":"115","author":"Goncalves","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model","volume":"92","author":"Costelli","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/bj2990071","article-title":"Pharmacological interference with tissue Hypercatabolism in Tumour-Bearing rats","volume":"299","author":"Tessitore","year":"1994","journal-title":"Biochem. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jcsm.12270","article-title":"Multiplatform plasma fingerprinting in cancer cachexia: A pilot observational and translational study","volume":"9","author":"Cala","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cmet.2016.10.010","article-title":"Tumor-Induced IL-6 reprograms host metabolism to suppress anti-tumor immunity","volume":"24","author":"Flint","year":"2016","journal-title":"Cell Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/000456329102800510","article-title":"Hormonal factors associated with weight loss in patients with advanced breast cancer","volume":"28","author":"Knapp","year":"1991","journal-title":"Ann. Clin. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"110238","DOI":"10.1016\/j.biopha.2020.110238","article-title":"Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes","volume":"128","author":"Eo","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I Stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, Atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00424-020-02367-4","article-title":"Irisin prevents dexamethasone-induced atrophy in C2C12 Myotubes","volume":"472","author":"Chang","year":"2020","journal-title":"Pflug. Arch."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.regpep.2005.08.003","article-title":"Regulation of apelin MRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes","volume":"132","author":"Wei","year":"2005","journal-title":"Regul. Pept."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-013-1692-9","article-title":"Identification of MicroRNAs involved in dexamethasone-induced muscle atrophy","volume":"381","author":"Shen","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"E1161","DOI":"10.1152\/ajpendo.00598.2009","article-title":"Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 Diabetic mice and humans","volume":"298","author":"Dray","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"789174","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Aulino, P., Berardi, E., Cardillo, V.M., Rizzuto, E., Perniconi, B., Ramina, C., Padula, F., Spugnini, E.P., Baldi, A., and Faiola, F. (2010). Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-363"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-005-1680-z","article-title":"A genetic and physiological study of impaired glucose homeostasis control in C57BL\/6J mice","volume":"48","author":"Toye","year":"2005","journal-title":"Diabetologia"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/7\/1814\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:49:09Z","timestamp":1760136549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/7\/1814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":81,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["cancers14071814"],"URL":"https:\/\/doi.org\/10.3390\/cancers14071814","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]}}}